11:09 AM EDT, 03/13/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were treading water late Thursday morning, edging 0.1% higher to 1,396.7 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by medical device maker EDAP TMS ( EDAP ) and pharmaceutical company Novo Nordisk ( NVO ) , which rose 4.7% and 3.3% respectively. They were followed by pharmaceutical company Ascendis Pharma ( ASND ) and telecommunications operator Telefonica ( TEF ) , which were up 1.7% and 1.5% respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications ( SQNS ) and software firm SAP (SAP), which fell 2.7% and 2.3% respectively. They were followed by biotechnology companies argenx (ARGX) and Evaxion Biotech ( EVAX ) , which dropped 2.1% and 0.9% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and telecommunications operator Vodafone Group ( VOD ) , which increased 5.2% and 3% respectively. They were followed by pharmaceutical companies Amarin ( AMRN ) and AstraZeneca ( AZN ) , which advanced 2.8% and 1.4% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana (NCNA) and Barclays (BCS), which lost 2.7% and 2.4% respectively. They were followed by biopharmaceutical companies TC Biopharm (TCBP) and Silence Therapeutics (SLN), which were down 1.8% and 1.2% respectively.